On Friday, Shares of Angie’s List, Inc. (NASDAQ:ANGI), surged 3.85% to $5.66.
On April 1, Angie’s List, surpassed 200,000 paid members in a single market, for the first time in company history.
“It’s no surprise that we reached the 200,000 member milestone in New York as the folks there have consistently seen the value of being informed consumers,” said Angie’s List founder Angie Hicks. “In addition, this milestone demonstrates that we are a leader in facilitating happy outcomes by giving homeowners the tools they need to shop, search and Snapfix.”
Angie’s List, Inc. operates a local services marketplace and consumer review site in the United States. The company provides marketplace to research, shop for, and purchase local services for home, health, and automotive service needs. It also allows its consumers to rate and review service providers in 253 markets.
Shares of RXi Pharmaceuticals Corporation (NASDAQ:RXII), gained 3.57% to $0.7250, during its last trading session.
RXi Pharmaceuticals Corporation, declared that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation of its second clinical candidate, Samcyprone™, for the treatment of Malignant Melanoma Stage IIb to IV. A number of patients with Stage IIb to IV malignant melanoma develop cutaneous metastases. Samcyprone™ is being developed for treatment of these metastases.
Samcyprone is a topical formulation of Diphenylcylcopropenone (DPCP) in clinical development for the treatment of warts, alopecia areata and cutaneous metastases of melanoma. The mechanism of action for treatment cutaneous metastases of melanoma involves elicitation of an immune response in the skin that subsequently causes destruction of the cutaneous tumor.
Melanomas, cancers that arise from melanocytes, are the most aggressive form of skin cancer. Once melanoma has spread beyond the localized area of the primary lesion, the survival rate decreases and melanoma becomes increasingly more difficult to treat successfully. Administration of metastatic melanoma, counting cutaneous metastases, is challenging and represents an area of great unmet need.
RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents.
At the end of Friday’s trade, Shares of China Ming Yang Wind Power Group Limited (NYSE:MY), gained 3.06% to $3.03.
China Ming Yang Wind Power Group Limited, declared that the Company will be attending the 2015 China International Capital Corporation Limited U.S. Conference held in New York on April 20 to April 22, 2015. Ming Yang’s CFO, Mr. Ricky Ng, will be in attendance as a panelist on the CICC Clean Energy Panel on April 22, 2015, Earth Day, which is founded to remind people to support clean energy, and Ricky will share his insights regarding the investment opportunities in China’s wind energy sector in terms of both technology and financial innovations. The conference will also feature prominent speakers such as Mr. Jonathan Silver, Former Director, Loan Program Office, U.S. Department of Energy and Dr. Henry A Kissinger, Former U.S. Secretary of State.
Ming Yang will also host a reception in New York on April 20, 2015.
China Ming Yang Wind Power Group Limited designs, manufactures, sells, and services megawatt-class wind turbines in the People’s Republic of China and the Republic of India. The company provides wind turbines with a rated power capacity of 1.5MW and 2.0MW; and 2.5/3.0MW SCD wind turbines.
Finally, Echo Global Logistics, Inc. (NASDAQ:ECHO), ended its last trade with 2.91% gain, and closed at $25.50.
Echo Global Logistics, declared the company was named 2014 Truckload Carrier of the Year by Berry Plastics Group, Inc. (NYSE:BERY). Evansville, Indiana-based Berry Plastics is a top provider of plastic packaging, tapes and adhesives and protection materials for numerous markets counting personal care, household food, beverage, foodservice, and healthcare.
Echo has raised its geographic coverage, allowing Berry Plastics to better leverage the expanded Echo carrier base. The partnership between the two companies has grown to a corporate, national level and resulted in deeper relationships, open communication and thus the prestigious recognition of the high performance and service offered by Echo.
Berry Plastics Group, Inc. is a leading provider of value-added plastic consumer packaging and engineered materials delivering high-quality customized solutions to our customers with annual net sales of $5 billion in fiscal 2014.
Echo Global Logistics, Inc. provides technology-enabled transportation and supply chain administration solutions in the United States. It uses a proprietary technology platform to compile and analyze data from its multi-modal network of motor, rail, and air freight transportation providers for the transportation and logistics needs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
